Innovating Works

ILLUMINA CAMBRIDGE LIMITED

Desconocido
GUIDE.MRD: GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD ILLUMINA CAMBRIDGE LIMITED participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-single-stage Advancing personalized approaches in cancer therapy, aiding identification and adaptation of multi-modal treatment strategies for improved o...
2023-05-17 - 2028-04-30 | Financiado
SCREEN4CARE: Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technol... ILLUMINA CAMBRIDGE LIMITED participó en un H2020: H2020-JTI-IMI2-2020-23-two-stage In the EU alone, according to the Orphanet DB (https://pubmed.ncbi.nlm.nih.gov/31527858/), 30 million persons, 3,5-6% of the general populat...
2021-10-13 - 2026-09-30 | Financiado
PANGAIA: Pan genome Graph Algorithms and Data Integration ILLUMINA CAMBRIDGE LIMITED participó en un H2020: H2020-MSCA-RISE-2019 Genomes are strings over the letters A,C,G,T, which represent nucleotides, the building blocks of DNA. In view of ultra-large amounts of gen...
2019-10-04 - 2025-06-30 | Financiado
ENGAGE: European Network for Genetic and Genomic Epidemiology ILLUMINA CAMBRIDGE LIMITED participó en un FP7: ENGAGE (European Network for Genetic and Genomic Epidemiology) has, as its central objective, the translation of the wealth of data emerging...
Financiado
GEUVADIS: Sharing capacity across Europe in high throughput sequencing technology to explore genetic variation... ILLUMINA CAMBRIDGE LIMITED participó en un FP7: High-throughput next-generation DNA sequencing technologies allow investigators to sequence entire human genomes at an affordable price and...
Financiado
ITFoM: IT Future of Medicine ILLUMINA CAMBRIDGE LIMITED participó en un FP7: Data-rich, individualised medicine poses unprecedented challenges for IT, in hardware, storage and communication. We propose a data-driven,...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.